| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M308334200 |
| P698 | PubMed publication ID | 12925525 |
| P50 | author | Albert Barbera | Q72108072 |
| Isabel Sanchez-Perez | Q73081859 | ||
| P2093 | author name string | Joan J Guinovart | |
| Ramon Gomis | |||
| Rosario Perona | |||
| Martine Caron | |||
| Ciro Mercurio | |||
| Susanna Baqué | |||
| M Carmen Muñoz | |||
| Delia Zafra | |||
| Jorge E Domínguez | |||
| P2860 | cites work | Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation | Q24528506 |
| Crystal structure and functional analysis of the SurE protein identify a novel phosphatase family | Q27634475 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin | Q28262178 | ||
| MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase | Q28278415 | ||
| Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study | Q28564460 | ||
| The renaissance of GSK3 | Q29616725 | ||
| Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. | Q30460881 | ||
| Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. | Q31809629 | ||
| Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice | Q33975117 | ||
| GSK3 takes centre stage more than 20 years after its discovery | Q34374129 | ||
| Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects | Q34893118 | ||
| Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucose | Q41328846 | ||
| The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated prote | Q41437636 | ||
| Mutation of tyrosine residues 1162 and 1163 of the insulin receptor affects hormone and receptor internalization | Q41745510 | ||
| Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling | Q42032355 | ||
| Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells | Q42808753 | ||
| Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. | Q42811852 | ||
| Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells | Q42830614 | ||
| Protein kinase C modulates the insulin-stimulated increase in Akt1 and Akt3 activity in 3T3-L1 adipocytes | Q42832240 | ||
| Inhibition of bacteriophage lambda protein phosphatase by organic and oxoanion inhibitors | Q43853894 | ||
| Modulation of glucose transporters in rat diaphragm by sodium tungstate | Q44428899 | ||
| Permolybdate and pertungstate--potent stimulators of insulin effects in rat adipocytes: mechanism of action | Q49292358 | ||
| An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats. | Q52038356 | ||
| Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase. | Q54154970 | ||
| Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cation | Q54255774 | ||
| Letter: Transition metal ion inhibition of enzyme-catalyzed phosphate ester displacement reactions. | Q54719293 | ||
| The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro | Q58450063 | ||
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 42785-42794 | |
| P577 | publication date | 2003-08-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway | |
| P478 | volume | 278 |
| Q54351172 | Activation of ERK by sodium tungstate induces protein synthesis and prevents protein degradation in rat L6 myotubes. |
| Q40035788 | Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage |
| Q57136256 | Characterizations and morphology of sodium tungstate particles |
| Q45285539 | Effects of sodium tungstate on oxidative stress enzymes in rats |
| Q28075738 | Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy |
| Q38904867 | In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line |
| Q42820960 | Inhibitory effect of CuSO₄ on α-glucosidase activity in ddY mice |
| Q46912061 | Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue |
| Q28577725 | Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses |
| Q33498114 | Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. |
| Q47910960 | Oral tungstate (Na2WO4) exposure reduces adaptive immune responses in mice after challenge |
| Q35618949 | Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans. |
| Q47145300 | Sodium Tungstate for Promoting Mesenchymal Stem Cell Chondrogenesis |
| Q43152965 | Sodium tungstate (Na2WO4) exposure increases apoptosis in human peripheral blood lymphocytes |
| Q44807995 | Sodium tungstate activates glycogen synthesis through a non-canonical mechanism involving G-proteins |
| Q46490425 | Sodium tungstate decreases sucrase and Na+/D-glucose cotransporter in the jejunum of diabetic rats |
| Q55531998 | The Antidiabetic Agent Sodium Tungstate Induces Abnormal Glycogen Accumulation in Renal Proximal Tubules from Diabetic IRS2-Knockout Mice. |
| Q28649323 | The elements of life and medicines |
| Q46592790 | The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D. |
| Q54395756 | Tungstate promotes β-cell survival in Irs2-/- mice. |
| Q27325843 | Tungstate reduces the expression of gluconeogenic enzymes in STZ rats |
| Q35557265 | Tungstate-targeting of BKαβ1 channels tunes ERK phosphorylation and cell proliferation in human vascular smooth muscle. |
Search more.